Showing 1 - 4 results of 4 for search 'Michael Foley', query time: 0.05s Refine Results
  1. 1
    Achieving optimal adherence to medical therapy by telehealth: Findings from the ORBITA medication adherence sub‐study

    Achieving optimal adherence to medical therapy by telehealth: Findings from the ORBITA medication adherence sub‐study by David Thompson, Rasha Al‐Lamee, Michael Foley, Hakim M. Dehbi, Simon Thom, Justin E. Davies, Darrel P. Francis, Prashanth Patel, Pankaj Gupta, ORBITA Investigators

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4

    Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4 by Katherine Griffiths, Uli Binder, William McDowell, Rita Tommasi, Mark Frigerio, William G. Darby, Chris G. Hosking, Lionel Renaud, Matthias Machacek, Peter Lloyd, Arne Skerra, Michael Foley

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes

    Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystem... by Alexandre J. S. Ribeiro, Brian D. Guth, Brian D. Guth, Michael Engwall, Sandy Eldridge, C. Michael Foley, Liang Guo, Gary Gintant, John Koerner, Stanley T. Parish, Jennifer B. Pierson, Mathew Brock, Khuram W. Chaudhary, Yasunari Kanda, Brian Berridge

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Adverse Drug-Induced Inotropic Effects in Early Drug Development. Part 1: General Considerations for Development of Novel Testing Platforms

    Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Adverse Drug-Induced Inotropic Effects in Early Drug Development. Part 1: General Considerations for De... by Brian D. Guth, Brian D. Guth, Michael Engwall, Sandy Eldridge, C. Michael Foley, Liang Guo, Gary Gintant, John Koerner, Stanley T. Parish, Jennifer B. Pierson, Alexandre J. S. Ribeiro, Tanja Zabka, Khuram W. Chaudhary, Yasunari Kanda, Brian Berridge

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: